Latest News & Features
Big Pharma
CureVac accuses Pfizer and its German partner of infringing patented tech in landmark COVID-19 treatment | The pharma giant says that the patents are invalid 6 September 2022
Americas
Massachusetts-based target company specialises in rare blood disorders | Deal gives Novo Nordisk access to lead development candidate, etavopivat. 2 September 2022
Americas
Lengthy opinion invalidated plaintiff’s patent but ruled that defendant’s would still infringe | Patents at issue related to treatment for high blood pressure in the lungs. 1 September 2022
Big Pharma
New partner brings pharma and chemistry focus, and boosts the European firm’s Unified Patent Court team. 1 September 2022
Americas
Suit claims a contractor used AltaThera secrets to launch a rival heart arrhythmia drug | Chicago-based company wants the court to add its founder as co-inventor on patent. 1 September 2022
article
O’Melveny has hired life sciences patent litigator Gregory Morris for its New York office as a partner in its IP and technology practice group. 30 August 2022
Generics
Pharma company facing lawsuit from two universities | Dispute centres on therapeutically effective co-crystals patent. 30 August 2022
Americas
Moderna has taken Pfizer and its German partner BioNTech to court, alleging that the pair copied Moderna’s technology when developing their COVID-19 vaccine. 30 August 2022
Big Pharma
Teva’s petition relies on a “blatantly misleading” question, argues GSK | Case presents “no new issues” that haven’t already been decided. 25 August 2022
Big Pharma
Safe harbour provisions can be relied on but their boundaries are still being defined, explain Jeanna Wacker and Tasha Francis Gerasimow of Kirkland & Ellis. 25 August 2022